Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove

eLife

Volumn 5, Issue JANUARY2016, 2016, Pages

  McMurtrey, Curtis ^a,b   Trolle, Thomas ^c,d   Sansom, Tiffany ^e   Remesh, Soumya G ^d   Kaever, Thomas ^d   Bardet, Wilfried ^a   Jackson, Kenneth ^a   McLeod, Rima ^f   Sette, Alessandro ^d   Nielsen, Morten ^c,g   Zajonc, Dirk M ^d   Blader, Ira J ^e   Peters, Bjoern ^d   Hildebrand, William ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Pure MHC LLC   (United States)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; HLA ANTIGEN CLASS 1; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE LIGAND; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTEIN BINDING; PROTOZOAL PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; PROTEIN ANALYSIS; THERMOSTABILITY; TOXOPLASMA GONDII; TOXOPLASMOSIS; CELL LINE; CHEMISTRY; IMMUNOLOGY; METABOLISM; MOLECULAR MODEL; MONOCYTE; PARASITOLOGY; PROTEIN CONFORMATION; TOXOPLASMA;

ANTIGENS, PROTOZOAN; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MODELS, MOLECULAR; MONOCYTES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; TOXOPLASMA;

EID: 84961942662     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.12556.001     Document Type: Article

References (50)

1. Battle R, Poole K, Haywood-Small S, Clark B, Woodroofe MN. 2013. Molecular characterisation of the monocytic cell line THP-1 demonstrates a discrepancy with the documented HLA type. International Journal of Cancer. Journal International Du Cancer 132:246-247. doi: 10.1002/ijc.27661
2. Blanchard N, Gonzalez F, Schaeffer M, Joncker NT, Cheng T, Shastri AJ, Robey EA, Shastri N. 2008. Immunodominant, protective response to the parasite toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunology 9:937-944. doi: 10.1038/ni.1629
3. Blanchard N, Shastri N. 2010. Topological journey of parasite-derived antigens for presentation by MHC class I molecules. Trends in Immunology 31:414-421. doi: 10.1016/j.it.2010.08.004
4. Brown CR, McLeod R. 1990. Class I MHC genes and CD8+ T cells determine cyst number in toxoplasma gondii infection. Journal of Immunology 145:3438-3441.
5. Burrows SR, Rossjohn J, McCluskey J. 2006. Have we cut ourselves too short in mapping CTL epitopes? Trends in Immunology 27:11-16. doi: 10.1016/j.it.2005.11.001
6. Cardona NI, Moncada DM, Gcomez-Marin JE. 2015. A rational approach to select immunogenic peptides that induce IFN-gamma response against toxoplasma gondii in human leukocytes. Immunobiology 220. doi: 10.1016/j.imbio.2015.07.009
7. Chen Y, Sidney J, Southwood S, Cox AL, Sakaguchi K, Henderson RA, Appella E, Hunt DF, Sette A, Engelhard VH. 1994. Naturally processed peptides longer than nine amino acid residues bind to the class i MHC molecule HLA-A2.1 with high affinity and in different conformations. Journal of Immunology 152:2874-2881.
8. Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (k1) and the concentration of inhibitor which causes 50 per cent inhibition (i50) of an enzymatic reaction. Biochemical Pharmacology 22:3099-3108.
9. Collaborative Computational Project, Number 4 (CCP4). 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallographica Section D, Biological Crystallography 50:760-763. doi: 10.1107/S0907444994003112
10. Collins EJ, Garboczi DN, Wiley DC. 1994. Three-dimensional structure of a peptide extending from one end of a class i MHC binding site. Nature 371:626-629. doi: 10.1038/371626a0
11. Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, El Bissati K, Zhou Y, Suzuki Y, Lee D, Woods S, Sommerville C, Henriquez FL, Roberts CW, McLeod R. 2012. Toxoplasma gondii HLA-b*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper t cell epitope elicits CD8(+) t cells producing interferon-gamma and reduces parasite burden in HLA-b*0702 mice. Human Immunology 73:1-10. doi: 10.1016/j.humimm.2011.10.006
12. Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R. 2010. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human t cell responses, and immunization of HLA-a*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+ T cell epitope based, adjuvanted vaccine protective against toxoplasma gondii. Immunome Research 6:12. doi: 10.1186/1745-7580-6-12
13. Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R. 2011. Towards an immunosense vaccine to prevent toxoplasmosis: protective toxoplasma gondii epitopes restricted by HLA-a*0201. Vaccine 29:754-762. doi: 10.1016/j.vaccine.2010.11.015
14. Deckert-Schluter M, Schluter D, Schmidt D, Schwendemann G, Wiestler OD, Hof H. 1994. Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. Infection and Immunity 62:221-228.
15. El Bissati K, Zhou Y, Dasgupta D, Cobb D, Dubey JP, Burkhard P, Lanar DE, McLeod R. 2014. Effectiveness of a novel immunogenic nanoparticle platform for toxoplasma peptide vaccine in HLA transgenic mice. Vaccine 32: 3243-3248. doi: 10.1016/j.vaccine.2014.03.092
16. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallographica Section D Biological Crystallography 60:2126-2132. doi: 10.1107/S0907444904019158
17. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of coot. Acta Crystallographica Section D, Biological Crystallography 66:486-501. doi: 10.1107/S0907444910007493
18. Feliu V, Vasseur V, Grover HS, Chu HH, Brown MJ, Wang J, Boyle JP, Robey EA, Shastri N, Blanchard N. 2013. Location of the CD8 t cell epitope within the antigenic precursor determines immunogenicity and protection against the toxoplasma gondii parasite. PLoS Pathogens 9:e1003449. doi: 10.1371/journal.ppat.1003449
19. Gajria B, Bahl A, Brestelli J, Dommer J, Fischer S, Gao X, Heiges M, lodice J, Kissinger JC, Mackey AJ, Pinney DF, Roos DS, Stoeckert CJ, Wang H, Brunk BP. 2008. ToxoDB: an integrated toxoplasma gondii database resource. Nucleic Acids Research 36:D553-556. doi: 10.1093/nar/gkm981
20. Garboczi DN, Madden DR, Wiley DC. 1994. Five viral peptide-HLA-A2 co-crystals. simultaneous space group determination and x-ray data collection. Journal of Molecular Biology 239:581-587. doi: 10.1006/jmbi.1994.1398
21. Goldszmid RS, Coppens I, Lev A, Caspar P, Mellman I, Sher A. 2009. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in toxoplasma gondii-infected dendritic cells. The Journal of Experimental Medicine 206:399-410. doi: 10.1084/jem.20082108
22. Grotzke JE, Cresswell P. 2015. Are ERAD components involved in cross-presentation? Molecular Immunology 68:112-115. doi: 10.1016/j.molimm.2015.05.002
23. Grover HS, Chu HH, Kelly FD, Yang SJ, Reese ML, Blanchard N, Gonzalez F, Chan SW, Boothroyd JC, Shastri N, Robey EA. 2014. Impact of regulated secretion on antiparasitic CD8+ T cell responses. Cell Reports 7:1716-1728. doi: 10.1016/j.celrep.2014.04.031
24. Gubbels MJ, Striepen B, Shastri N, Turkoz M, Robey EA. 2005. Class i major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of toxoplasma gondii. Infection and Immunity 73:703-711. doi: 10.1128/IAI.73.2.703-711.2005
25. Gulukota K, Sidney J, Sette A, DeLisi C. 1997. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. Journal of Molecular Biology 267:1258-1267. doi: 10.1006/jmbi.1997.0937
26. Hassan C, Chabrol E, Jahn L, Kester MG, de Ru AH, Drijfhout JW, Rossjohn J, Falkenburg JH, Heemskerk MH, Gras S, van Veelen PA. 2015. Naturally processed non-canonical HLA-a*02:01 presented peptides. The Journal of Biological Chemistry 290:2593-2603. doi: 10.1074/jbc.M114.607028
27. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M. 2009. NetMHCpan, a method for MHC class i binding prediction beyond humans. Immunogenetics 61:1-13. doi: 10.1007/s00251-008-0341-z
28. Horig H, Young AC, Papadopoulos NJ, DiLorenzo TP, Nathenson SG. 1999. Binding of longer peptides to the h-2Kb heterodimer is restricted to peptides extended at their c terminus: refinement of the inherent MHC class I peptide binding criteria. Journal of Immunology 163:4434-4441.
29. Khan IA, Smith KA, Kasper LH. 1988. Induction of antigen-specific parasiticidal cytotoxic t cell splenocytes by a major membrane protein (p30) of toxoplasma gondii. Journal of Immunology 141:3600-3605.
30. Kim Y, Yewdell JW, Sette A, Peters B. 2013. Positional bias of MHC class i restricted t-cell epitopes in viral antigens is likely due to a bias in conservation. PLoS Computational Biology 9:e1002884. doi: 10.1371/journal.pcbi.1002884
31. Lanteri MC, Kaidarova Z, Peterson T, Cate S, Custer B, Wu S, Agapova M, Law JP, Bielawny T, Plummer F, Tobler LH, Loeb M, Busch MP, Bramson J, Luo M, Norris PJ. 2011. Association between HLA class i and class II alleles and the outcome of west nile virus infection: an exploratory study. PloS One 6:e22948. doi: 10.1371/journal.pone.0022948
32. McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, Wahl A, Bardet W, Eckerd A, Cook RL, Hess R, Buchli R, Loeb M, Rinaldo CR, Bramson J, Hildebrand WH. 2008. Epitope discovery in west nile virus infection: identification and immune recognition of viral epitopes. Proceedings of the National Academy of Sciences of the United States of America 105:2981-2986. doi: 10.1073/pnas.0711874105
33. Mitaksov V, Truscott SM, Lybarger L, Connolly JM, Hansen TH, Fremont DH. 2007. Structural engineering of pMHC reagents for t cell vaccines and diagnostics. Chemistry and Biology 14:909-922. doi: 10.1016/j.chembiol.2007.07.010
34. Otwinowski Z, Minor W. 1997. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326. doi: 10.1016/S0076-6879(97)76066-X
35. Potterton E, Briggs P, Turkenburg M, Dodson E. 2003. A graphical user interface to the CCP 4 program suite. Acta Crystallographica Section D Biological Crystallography 59:1131-1137. doi: 10.1107/S0907444903008126
36. Schittenhelm RB, Sian TCCLK, Wilmann PG, Dudek NL, Purcell AW. 2015. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis and Rheumatology 67:702-713. doi: 10.1002/art.38963
37. Scull KE, Dudek NL, Corbett AJ, Ramarathinam SH, Gorasia DG, Williamson NA, Purcell AW. 2012. Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA a*02:01 ligands. Molecular Immunology 51:136-142. doi: 10.1016/j.molimm.2012.02.117
38. Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, Peters B. 2008. Quantitative peptide binding motifs for 19 human and mouse MHC class i molecules derived using positional scanning combinatorial peptide libraries. Immunome Research 4:2. doi: 10.1186/1745-7580-4-2
39. Sidney J, Southwood S, Mann DL, Fernandez-Vina MA, Newman MJ, Sette A. 2001. Majority of peptides binding HLA-a*0201 with high affinity crossreact with other A2-supertype molecules. Human Immunology 62:1200-1216. doi: 10.1016/S0198-8859(01)00319-6
40. Sidney J, Southwood S, Moore C, Oseroff C, Pinilla C, Grey HM, Sette A. 2013. Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture. Curr Protoc Immunol Chapter 18:Unit 18. doi: 10.1002/0471142735.im1803s100
41. Storoni LC, McCoy AJ, Read RJ. 2004. Likelihood-enhanced fast rotation functions. Acta Crystallographica. Section D, Biological Crystallography 60:432-438. doi: 10.1107/S0907444903028956
42. Suzuki Y, Remington JS. 1988. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. Journal of Immunology 140:3943-3946.
43. Treeck M, Sanders JL, Elias JE, Boothroyd JC. 2011. The phosphoproteomes of plasmodium falciparum and toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries. Cell Host and Microbe 10:410-419. doi: 10.1016/j.chom.2011.09.004
44. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (tHP-1). International Journal of Cancer 26:171-176. doi: 10.1002/ijc.2910260208
45. Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL, van Zuylen WJ, Purcell AW, Kjer-Nielsen L, McCluskey J, Burrows SR, Rossjohn J. 2005. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class i. implications for t-cell receptor engagement and t-cell immunodominance. The Journal of Biological Chemistry 280:23900-23909. doi: 10.1074/jbc.M503060200
46. Wahl A, Schafer F, Bardet W, Buchli R, Air GM, Hildebrand WH. 2009. HLA class i molecules consistently present internal influenza epitopes. Proceedings of the National Academy of Sciences of the United States of America 106:540-545. doi: 10.1073/pnas.0811271106
47. Walden M, Crow A, Nelson MD, Banfield MJ. 2014. Intramolecular isopeptide but not internal thioester bonds confer proteolytic and significant thermal stability to the s. pyogenes pilus adhesin Spy0125. Proteins 82:517-527. doi: 10.1002/prot.24420
48. Wiley M, Sweeney KR, Chan DA, Brown KM, McMurtrey C, Howard EW, Giaccia AJ, Blader IJ. 2010. Toxoplasma gondii activates hypoxia-inducible factor (hIF) by stabilizing the HIF-1alpha subunit via type i activin-like receptor kinase receptor signaling. The Journal of Biological Chemistry 285:26852-26860. doi: 10.1074/jbc.M110.147041
49. Xia D, Sanderson SJ, Jones AR, Prieto JH, Yates JR, Bromley E, Tomley FM, Lal K, Sinden RE, Brunk BP, Roos DS, Wastling JM. 2008. The proteome of toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation. Genome Biology 9:R116. doi: 10.1186/gb-2008-9-7-r116
50. Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, Cederno S, Plana M, Mothe B, Brander C, West JT, Hildebrand WH. 2014. Direct interrogation of viral peptides presented by the class i HLA of HIV-infected t cells. Journal of Virology 88:12992-13004. doi: 10.1128/JVI.01914-14